However, they decreased progressively for both groups (2/6 for the STI group and 1/6 for the IL-2 group at week 0-end of 4th STI-), and, at week 48, all but one patient in the IL-2 group had lost these HIV-specific CD4 responses. The gene discussed is IL2; the disease is sexually transmitted disease.